ARYx Therapeutics

From Wikipedia, the free encyclopedia
Jump to: navigation, search

ARYx Therapeutics, Inc. (OTC Pink: ARYX) is an American biopharmaceutical company, headquartered in Fremont, California, focused on molecular design.

The company uses its RetroMetabolic Drug Design technology to design molecules that retain the efficacy of original and well-established drugs but which are metabolized through a potentially safer pathway to avoid specific adverse side effects associated with these original compounds.


External links[edit]